MEI Pharma Reports Third Quarter Fiscal Year 2025 Cash Position
ReutersMay 13, 2025 8:26 PM
May 13 (Reuters) - MEI Pharma Inc MEIP.O:
MEI PHARMA REPORTS THIRD QUARTER FISCAL YEAR 2025 CASH POSITION
MEI PHARMA INC: EVALUATION OF STRATEGIC ALTERNATIVES IS ONGOING
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
[Reuters Breakingviews] Tame April CPI rise doesn't yet capture tariff impact
May 13 (Reuters) - U.S. consumer prices rebounded moderately in April, but inflation is likely to pick up in the months as tariffs boost the cost of imported goods.The consumer price index CPI increased 0.2% last month after dipping 0.1% in March, which was the first decline since May 2020, the LaboReuters
4 hours ago
Walmart (WMT) Q1 2026 Earnings Preview: What to Expect from the Retail Giant’s Earnings?
Walmart will report its first quarterly earnings for this fiscal year on Thursday, after the bell. As one of the largest retailers in the country, Walmart results can serve as a reliable proxy for grasping the US consumer sentiment, especially in the context of the recent economic woes.TradingKey
20 hours ago
Tesla Q1 2025 Earning Report Review: Autonomous Driving and Robotics Lead Future Growth
TradingKey - Tesla's Q1 2025 earnings results revealed short-term financial pressure, with core data lower than market expectations, and both revenue and profitability facing challenges. Against the backdrop of sales and profit pressure, Musk remains confident in Tesla's future.TradingKey
Wed, Apr 23
Bank of Japan Interest Rate Decision Preview: Pause on Rate Hikes Already Priced In, Minimal Market Movement Expected on the Day
On 19 March 2025, the Bank of Japan (BoJ) will announce its March interest rate decision. The market widely expects the central bank to maintain its policy rate unchanged at 0.5%. We align with this consensus forecast.TradingKey
Tue, Mar 18
